Psychiatry

Dr. Rakesh Jetly is leading a new phase 2 study testing psychedelics in veterans with PTSD.

Researchers will soon test psychosubstances as a potential treatment for veterans with PTSD.

When compared to standard care, a new CBT method results in a greater drop in SDQ Impact scores.

The mortality rate was higher in ASD patients with SUD than it was for a control group not suffering from ASD.

Investigators believe using a computational system could allow clinicians to have a better read on which treatments could be effective in adolescents with ADHD.

The 5 companies issued letters will have 15 days to submit a compliance plan.

Despite these findings, there is still uncertainty as to whether mitigating symptoms of depression can lower cardiovascular risk.

There are numerous individual and systemic barriers that preclude this vulnerable population from taking preventative measures.

Preschool children with asthma, food allergies, and pollen/fur or dust mite allergies are at increased risk of having concurrent mental health problems.

More studies are needed to examine other methods of ADHD assessments.

Experts expect more individuals to face mental health challenges caused by the events of 2020.

Repeated Transcranial Magnetic Stimulation shows more efficacy treating bipolar disorder than schizophrenia.

Inflammatory bowel disease patients were surveyed about their remission or flare-up status, as well as their expectations for a flare-up over the next 2 months.

The risk of suicidality and psychological adverse events appears to be particularly high in younger men with alopecia who are given finasteride.

The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.

An interview with a pain specialist on advancing alternative pain therapy options.

The first-line atypical antipsychotic was linked to better outcomes in patients than comparators aripiprazole and olanzapine.

Investigators find frailty is a key risk factor for age-related cognitive dysfunction and dementia.

The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.

The study authors noted that dementia prevention could become a compelling indication for older individuals receiving antihypertensive treatment.

Nightware provides vibrations when it senses the user is having a nightmare.

Supernus indicates no efficacy or safety concerns from their pediatric ADHD medication.

A greater number of cumulative days of montelukast use did not increase the risk of ADHD in these patients.

Researchers have been unable to leverage new technology for ADHD screening.

Dr. David Goodman discusses the gaps in ADHD treatment.